September 23rd 2025, 3:00pm
Tecvayli and Darzalex demonstrated meaningful clinical efficacy in transplant-eligible patients with newly diagnosed multiple myeloma.
September 23rd 2025, 1:00pm
Dr. Prithviraj Bose discussed the current treatment landscape for myeloproliferative neoplasms, a group of rare blood cancers; he focused on myelofibrosis.
September 22nd 2025, 9:00pm
Molecular testing helps distinguish kidney cancer subtypes, ensuring patients get accurate diagnoses and treatment plans, avoiding unnecessary surgery.
September 22nd 2025, 8:00pm
Patients need long-term monitoring after gastrointestinal stromal tumor surgery, with some requiring extra treatment or genetic testing to lower recurrence risk.
September 22nd 2025, 7:00pm
Dr. Ravi Munver sat down for an interview with CURE to discuss progress in kidney cancer care.
September 22nd 2025, 5:00pm
I was diagnosed with colon cancer at 17, and while I’ll always be part of the AYA community, turning 40 has shown me the gift of growing older.
September 22nd 2025, 4:00pm
CURE spoke with nurse and breast cancer survivor Amanda Davis at the John Theurer Cancer Center.
September 22nd 2025, 3:01pm
Giredestrant plus Afinitor improved survival without progression in ER-positive advanced breast cancer.
September 22nd 2025, 1:00pm
Dr. Christina Cho highlights the Adult Stem Cell Transplant and Cellular Therapy Program for its innovative research and compassionate, multidisciplinary team.
September 21st 2025, 2:00pm
Learn how myelodysplastic syndrome treatment has advanced with targeted therapies and anemia management while balancing quality of life for patients.
Basal Cell Carcinoma Basics, From Diagnosis to Treatment
Stage 2 Cervical Cancer: Key Facts and Updates for Patients
HR+/HER2– Breast Cancer: Diagnosis and Treatment Guide
So You Want To Be A Cancer Advocate